ALLIANCE A031702 Primary Category: Treatment Protocols Disease Category: Bladder, Genitourinary, Prostate, Renal Status: Open A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC) (Click for More Info) NCT#03866382